top of page
Phone: 888-855-0947 Office Hours: M-F 10am-6pm Fax: 346-766-0599
After hours: If urgent, life threatening (please call 988, 911, or go to nearest ER. Otherwise, for side effects to medications, please text 816-766-0119. For all other non-urgent issues, please contact us Practice Q messaging portal or contact us during clinic hours at 888-855-0947.
two women talking and smiling
a boy bow down on floor
a women crying while holding a hand
two women talking and smiling
1/3
Ready for your Mental Health Transformation?
Child Psychiatrist /Adult Psychiatrist
Blog
Search
Oral Extended-Release Ketamine Promising for Treatment-Resistant Depression
An extended-release oral tablet formulation of ketamine has shown promise for treatment-resistant depression (TRD) results of a phase 2...
Vilash Reddy, MD
Jun 25, 20243 min read
2
0
Early-Life Exposure to Pollution Linked to Psychosis, Anxiety, Depression
Early-life exposure to air and noise pollution is associated with a higher risk for psychosis, depression, and anxiety in adolescence and...
Vilash Reddy, MD
Jun 14, 20243 min read
0
0
Teen Cannabis Use Tied to Dramatic Increased Risk for Psychosis
Teenagers who use cannabis have a dramatic increased risk for a psychotic disorder compared with their counterparts who don't use the...
Vilash Reddy, MD
Jun 5, 20243 min read
3
0
What Is the Optimal Dose of Ketamine for Treatment Resistant Depression?
Keypoint: Higher IV ketamine doses do not outperform standard doses for treatment resistant depression. Intravenous (IV) ketamine for...
Vilash Reddy, MD
May 6, 20242 min read
3
0
Antidepressants Differ by Long-Term Response in Major Depression
Antidepressants differ in improving symptoms and preventing relapse of major depressive disorder (MDD) over a 2-year period, according to...
Vilash Reddy, MD
May 1, 20244 min read
2
0
Managing Suicidal Thoughts, Behaviors, and Risk in Treatment-Resistant Depression
Suicidal thoughts and behaviors (STBs) are among the most dreaded complications of treatment-resistant depression (TRD), which is...
Vilash Reddy, MD
Apr 17, 20247 min read
2
0
Depression in Older Adults Accelerates Multimorbidity Progression
Keypoint: Older adults with depression are at increased risk for highly complex multimorbidity. Older adults with depression have a more...
Vilash Reddy, MD
Apr 16, 20243 min read
0
0
Psychosocial Interventions Improve Depression and Anxiety During Menopause
Keypoint: People experiencing psychological symptoms of menopause may benefit from CBT or mindfulness. Psychosocial interventions of...
Vilash Reddy, MD
Apr 12, 20242 min read
1
0
Combination Therapy of SSRIs and SGAs Is Optimal for Psychotic Depression
Keypoint: These findings provide specific recommendations for the most efficacious psychotic depression treatment options. The...
Vilash Reddy, MD
Apr 4, 20242 min read
17
0
Duration of Daily Depressive Behaviors Among Preschoolers Linked to Impairment
Keypoint: Duration of depressive symptoms in preschool-aged children is positively correlated with daily impairment and distress. Study...
Vilash Reddy, MD
Apr 1, 20243 min read
4
0
Review: Exercise Is Effective Treatment for Depression
HealthDay News — Exercise is an effective treatment for depression, especially when intense, according to a review published online Feb....
Vilash Reddy, MD
Mar 15, 20241 min read
5
0
The Importance of Refining the Depression Diagnosis
SPECIAL REPORT: TREATMENT-RESISTANT DEPRESSION DIAGNOSIS The goal of this Special Report is to help you manage treatment-resistant...
Vilash Reddy, MD
Jan 25, 20244 min read
15
0
FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
HealthDay News — The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug...
chrisviesumalinog
Nov 7, 20236 min read
8
0
Concurrent Treatment of Eating Disorders and PTSD Leads to Long-Term Recovery
Concurrent treatments targeting eating disorders and PTSD are needed to help these patients with complex conditions. Research shows an...
chrisviesumalinog
Nov 7, 20235 min read
14
0
Early Sleep Improvement and Response to Pharmacotherapy in Psychotic Depression
Does early improvement in insomnia predict response to pharmacotherapy in psychotic depression? Authors performed a secondary analysis of...
chrisviesumalinog
Nov 7, 20234 min read
12
0
Pandemic-Era Telehealth Led to Fewer Therapy Disruptions
Disruptions TOPLINE: US adults with psychiatric illness experienced fewer disruptions in receiving psychotherapy following the transition...
chrisviesumalinog
Nov 7, 20232 min read
2
0
GLP-1 Agonists and Suicide Risk: What Action Should Be Taken?
GLP-1 Agonists and Suicide Risk A statement from the European Medicines Agency (EMA) about semaglutide and, more generally, glucagon-like...
chrisviesumalinog
Nov 7, 20234 min read
22
0
Esketamine Bests Quetiapine for Severe Depression in Head-to-Head Trial
Esketamine Bests Quetiapine for Severe Depression in Head-to-Head Trial BARCELONA — Intranasal esketamine (Spravato, Janssen) is superior...
chrisviesumalinog
Nov 7, 20234 min read
6
0
People With Long COVID Face Alarming Rates of Depression, Anxiety: Expert Q&A
Editor's note: Find the latest long COVID news and guidance in Medscape's Long COVID Resource Center. As many as 2 out of 3 people with...
chrisviesumalinog
Nov 7, 20235 min read
24
0
Greater ADHD Symptoms Reported by Adults With Adverse Childhood Experiences
Adults with greater adverse childhood experiences (ACEs) have higher attention deficit hyperactivity disorder (ADHD) symptom reporting...
chrisviesumalinog
Nov 7, 20233 min read
23
0
bottom of page